Cargando…
Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
Myelin oligodendrocyte glycoprotein antibody associated disease (MOG-AD) is a CNS demyelinating disease, typically presenting with optic neuritis, transverse myelitis, and/or ADEM-like syndromes. The positive predictive value (PPV) of MOG-IgG testing by live cell-based assay was reported to be 72% i...
Autores principales: | Manzano, Giovanna S., Salky, Rebecca, Mateen, Farrah J., Klawiter, Eric C., Chitnis, Tanuja, Levy, Michael, Matiello, Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251463/ https://www.ncbi.nlm.nih.gov/pubmed/35795797 http://dx.doi.org/10.3389/fneur.2022.947630 |
Ejemplares similares
-
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
por: Brill, Livnat, et al.
Publicado: (2021) -
Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020) -
MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020) -
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
por: Bollo, Luca, et al.
Publicado: (2021) -
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)